Validation of the Korean Version of the Prodromal Questionnaire-Brief Version in Non-Help-Seeking Individuals
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Young Eun | - |
dc.contributor.author | Lee, Tae Young | - |
dc.contributor.author | Hur, Ji-Won | - |
dc.contributor.author | Kwon, Jun Soo | - |
dc.date.accessioned | 2021-09-01T20:21:32Z | - |
dc.date.available | 2021-09-01T20:21:32Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-02 | - |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/67887 | - |
dc.description.abstract | Objective In this study, we examined the reliability and validity of the Korean version of the Prodromal Questionnaire-Brief (PQ-B), a self-report screening instrument for clinical high risk for psychosis (CHR). Methods A total of 3,400 middle, high school and college students participated, and 261 subjects with a PQ-B total score >= 3 completed both the PQ-B and the Structured Interview for Prodromal Syndromes (SIPS). Receiver operating characteristic (ROC) curves were used to examine the psychometric properties of the PQ-B. Results A cut off of 7 for the PQ-B total score and a cut-off of 22 for the PQ-B distress score showed the best balance of sensitivity (72.2%, 77.8%) and specificity (71.4%, 75.0%). Conclusion The Korean version of the PQ-B showed good reliability and validity for predicting prodromal risk symptoms in the community population. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN NEUROPSYCHIATRIC ASSOC | - |
dc.subject | CLINICAL HIGH-RISK | - |
dc.subject | ULTRA-HIGH RISK | - |
dc.subject | PSYCHOSIS-RISK | - |
dc.subject | AT-RISK | - |
dc.subject | UNTREATED PSYCHOSIS | - |
dc.subject | PRIME SCREEN | - |
dc.subject | DSM-V | - |
dc.subject | SCHIZOPHRENIA | - |
dc.subject | SYMPTOMS | - |
dc.subject | STATE | - |
dc.title | Validation of the Korean Version of the Prodromal Questionnaire-Brief Version in Non-Help-Seeking Individuals | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hur, Ji-Won | - |
dc.identifier.doi | 10.30773/pi.2018.10.23 | - |
dc.identifier.scopusid | 2-s2.0-85065647842 | - |
dc.identifier.wosid | 000459395200003 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY INVESTIGATION, v.16, no.2, pp.109 - 114 | - |
dc.relation.isPartOf | PSYCHIATRY INVESTIGATION | - |
dc.citation.title | PSYCHIATRY INVESTIGATION | - |
dc.citation.volume | 16 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 109 | - |
dc.citation.endPage | 114 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002440029 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | CLINICAL HIGH-RISK | - |
dc.subject.keywordPlus | ULTRA-HIGH RISK | - |
dc.subject.keywordPlus | PSYCHOSIS-RISK | - |
dc.subject.keywordPlus | AT-RISK | - |
dc.subject.keywordPlus | UNTREATED PSYCHOSIS | - |
dc.subject.keywordPlus | PRIME SCREEN | - |
dc.subject.keywordPlus | DSM-V | - |
dc.subject.keywordPlus | SCHIZOPHRENIA | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | STATE | - |
dc.subject.keywordAuthor | Schizophrenia | - |
dc.subject.keywordAuthor | Early psychosis | - |
dc.subject.keywordAuthor | Clinical high risk | - |
dc.subject.keywordAuthor | Ultra high risk | - |
dc.subject.keywordAuthor | Screening | - |
dc.subject.keywordAuthor | PQ-B | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.